Vaccine Paper 2.docx - Inactivated poliovirus(IPV Inactivated influenza(IIV Inactivated poliovirus(IPV Trade name Ipol(Poliovax Type of vaccination

Vaccine Paper 2.docx - Inactivated poliovirus(IPV...

This preview shows page 1 - 2 out of 4 pages.

Inactivated poliovirus (IPV) & Inactivated influenza (IIV) Inactivated poliovirus (IPV) Trade name: Ipol (Poliovax) Type of vaccination: Inactivated Contraindications: IPV should not be administered to a patient who has had an anaphy- lactic reaction to a previous IPV dose. IPV should also not be administered to a patient who has had an anaphylactic reaction to the following medications; streptomycin, polymyxin B, or neomycin. Precautions: IPV SHOULD be administered to immunodeficient patients and those they live with. Adverse drug reactions: Vaccine-Associated Paralytic Poliomyelitis (VAPP) (only associ- ated with oral polio vaccine), and Guillain-Barr é Syndrome (GBS). Minimum age to receive the vaccine: 6 weeks Routine recommended vaccine schedule: 4-dose IPV series should be administered at ages 2 months, 4 months, 6-18 months, and 4-6 years. The final dose should be administered at 4 years or older regardless of the number of previous doses. The minimum time from dose 3 to dose 4 is 6 months, and the minimum time from dose 1 to dose 2, and from dose 2 to dose 3, is 4 weeks. Dosage for adults and children is .5ml.

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture